AstraZeneca’s Uncertain Future After Failed Merger Talks
AstraZeneca's halted merger talks raise questions about its future strategy and investor confidence.
AstraZeneca's halted merger talks raise questions about its future strategy and investor confidence.
AstraZeneca's shares fell sharply amid merger talks, raising investor concerns about future direction.
GSK's new research centre in Cambridge signals a positive shift for the UK pharmaceutical industry.
Novo Nordisk sues Eli Lilly for allegedly misleading advertising in a competitive drug market.